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Abstract 
Past studies have suggested that pulsed electromagnetic field (PEMF) therapy can 
decrease pain. To date, however, it remains difficult to determine if the analgesic effect 
observed in patients are attributable to a direct effect of PEMF on pain or to an indirect 
effect of PEMF on inflammation and healing. In the present study, we used an 
experimental pain paradigm to evaluate the direct effect of PEMF on pain intensity, pain 
unpleasantness and temporal summation of pain. Twenty-four healthy subjects (mean age 
22 ± 2 years; 9 males) participated in the experiment. Both real and sham PEMF were 
administered to every participant using a randomized, double-blind, cross-over design. 
For each visit, PEMF was applied for 10 minutes on the right forearm using a portable 
device. Experimental pain was evoked before (baseline) and after PEMF with a 9 cm2 
Pelletier type thermode, applied on the right forearm (120 sec stimulation; temperature 
individually adjusted to produce moderate baseline pain). Pain intensity and 
unpleasantness were evaluated using a 0-100 numerical pain rating scale. Temporal 
summation was evaluated by comparing pain intensity ratings obtained at the end of tonic 
nociceptive stimulation (120 sec) with pain intensity ratings obtained after 60 sec of 
stimulation. When compared to baseline, there was no change in pain intensity and 
unpleasantness following the application of real or sham PEMF. PEMF did not affect 
temporal summation. The present observations suggest that PEMF does not directly 
influence heat pain perception in healthy individuals.
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1. Introduction
Pulsed electromagnetic field (PEMF) therapy is a non-pharmacological modality 
that uses electromagnetic fields to accelerate tissue healing and foster recovery (Bachl et 
al. 2008; Markov 2007). In the past years, a number of studies have suggested that PEMF 
may also reduce pain (Bachl et al. 2008; Binder et al. 1984; Foley-Nolan et al. 1990; 
Kroeling et al. 2005). Although the physiological mechanisms responsible for PEMF 
analgesia remain uncertain, some authors have suggested that PEMF could influence pain 
via its effect on nitric oxide (NO), calmodulin (CaM) and/or opioid pathways (Abramson 
2008; Diniz et al. 2002; Fitzsimmons et al. 2008; Pilla 2013; Staniland et al. 2010). To 
date however, results of studies looking into the effects of PEMF on pain have been 
inconsistent (Pieber et al. 2010; Ryang We et al. 2013; Teasell et al. 2010; Vavken et al. 
2009). Given the effect of PEMF on tissue repair pathways (Callaghan et al. 2008; 
Fitzsimmons et al. 2008; Pilla et al. 2011), it also remains difficult to determine if the 
analgesic effect observed in patients who received PEMF is attributable to a direct effect 
of PEMF on pain or to an indirect effect of PEMF on inflammation and healing. 
Experimental pain paradigms are interesting research avenues that can be used to 
evaluate the analgesic effect of therapeutic interventions (Olesen et al. 2012). Many 
experimental pain paradigms allow for the assessment of pain and nociceptive responses 
in the absence of tissue injury or inflammation, thus offering a unique opportunity to 
evaluate the direct analgesic effect of a given intervention. To date, very few studies 
evaluated the analgesic effects of PEMF using experimental pain (Fernandez et al. 2007; 
Kortekaas et al. 2013; Shupak et al. 2004). 
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Recently, Robertson et al. (2010) reported that the use of a whole-body 
electromagnetic field – applied during a painful stimulus with a strong static field of a 
magnetic resonance imaging instrument – decreases the activity of brain areas involved in 
the perception of the affective component of pain (Apkarian et al. 2005; Marchand 2010). 
Even though the results of Robertson et al. were obtained following whole-body 
electromagnetic field exposure rather than local electromagnetic field exposure (as is 
generally the case in clinical settings), their results raise the possibility that PEMF might 
preferentially influence the affective component of pain (pain unpleasantness), rather 
than the sensori-discriminative component of pain (pain intensity). In their study 
however, Robertson et al. did not report the effect of PEMF on subjective pain ratings, 
hence precluding any final conclusion regarding the effect of PEMF on the affective 
component of pain. 
The lack of consensus regarding the analgesic effect of PEMF, as well as the 
absence of studies evaluating the effect of PEMF on the affective component of pain, 
emphasizes the necessity of conducting additional studies to assess the effect of PEMF on 
pain. In the present study, we evaluated the effect of PEMF on the two main components 
of pain (pain intensity and pain unpleasantness) by using an experimental tonic heat pain 
paradigm.  The use of an experimental pain paradigm was preferred in order to exclude 
the effect that PEMF could have on inflammation and tissue repair. It also offered a 
unique opportunity to verify if PEMF could have an effect on temporal summation, an 
excitatory pain mechanism implicated in central sensitization and chronic pain (Katz and 
Rothenberg 2005; Vadivelu et al. 2010). 
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2. Methods 
2.1 Participants 
Twenty-four healthy subjects (mean age 22 ± 2 years; 9 males) participated in this 
study. Participants were recruited through ads posted throughout Sherbrooke University’s 
Health Campus. The experiment took place at the Clinique universitaire de réadaptation 
de l’Estrie, an outpatient clinic located in the Faculté de médecine et des sciences de la 
santé de l’Université de Sherbrooke (Canada). None of the participants suffered from any 
known diseases, had any recent musculoskeletal injury to the upper limbs, nor were they 
on any medication (except oral contraceptives). For security reasons, participants with a 
pacemaker or metal implants were excluded. Every participant was asked to refrain from 
consuming caffeine and smoking cigarettes 6 h before testing. The Research Ethics Board 
for the Research Center on Aging of the Health and Social Services Center – Sherbrooke 
University Geriatrics Institute, approved the study’s procedures and each participant 
provided informed consent before participation. 
2.2 Tonic heat pain model 
Participants were seated comfortably in a reclining chair. Before each session, a 
pre-testing session was done in order to familiarize the participants with the thermode 
and to determine the temperature that would be used during the 2 min pain test. This pre-
test was performed with a 9 cm2 Peltier-type thermode (Medoc, Advanced Medical 
Systems, Ramat Yishai, Israel) applied on the ventral surface of the left forearm. 
Participants were told that the temperature of the thermode would gradually rise (from 32 
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to 51 C, rising rate = 0.3 C/sec). The pre-test procedure was repeated twice during 
which subjects verbally reported their pain perception and pain tolerance thresholds. On 
the third pre-test, subjects were given a computerized visual analogue scale (COVAS; 
Medoc, Advanced Medical Systems, Ramat Yishai, Israel) and advised that they would 
have to start moving the cursor towards to right (past the ‘‘0” mark) when they would 
start feeling pain (pain perception threshold) and that the cursor would need to be at the 
extreme right (at the “100” mark) when pain would become intolerable (pain tolerance 
threshold). This procedure was repeated until the subject’s pain reports were consistent 
between trials. The temperature used during the following experimental heat pain test 
was determined by selecting the temperature for which the subject had rated the pain 
intensity at 50/100 with the COVAS (moderate pain). 
Following the pre-test, participants were given a 10 min rest period before the 
experimental test began. The tonic pain test was then performed with the application of 
the thermode at constant temperature (determined during the pre-test) applied on the right 
forearm for 2 min. Subjects were told that the temperature of the thermode could rise, 
remain stable or decrease and that they would have to verbally report pain intensity and 
unpleasantness with a 0-100 numerical rating scale (NRS) (pain intensity : 0 = no pain, 
100 = unbearable pain; pain unpleasantness : 0 = not at all unpleasant, 100 = extremely 
unpleasant) every 15 s during the 2 min test. In fact, after a constant rise (0.3 C/sec) 
from baseline (32 C) to the individually predetermined temperature, the thermode’s 
temperature remained constant throughout the 120 sec. It was necessary to obtain pain 
measures every 15 sec during the 2 min thermode test in order to evaluate temporal 
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summation (Tousignant-Laflamme et al. 2008). The thermode test was repeated 
immediately after the application of the PEMF, as well as every 15 min afterwards for the 
next hour.  To avoid pain sensitization, the thermode was applied on an adjacent region 
of the right forearm, but never on the same site. 
2.3 PEMF application 
PEMF was administered on the right forearm, except in the case of one participant 
who received PEMF (and the thermode heat pain test) on the left forearm due to a past 
fracture of the right forearm. PEMF was delivered with a Rhumart Self-Health™ MBI-
3000 apparatus (SEM Electronique, Quebec, Canada) and two REBONE-4A applicators 
(Begue-Simon and Drolet 1993). Before the study, the Rhumart apparatus was evaluated 
by a certified operator to ensure proper calibration of the device. Both the real and sham 
interventions were applied for 10 min. For the real intervention, the frequency was set at 
60 Hz and the amplitude of the oscillating signal at 30% of the maximal stimulator output 
(30% x 30 Gauss = 9 Gauss; continuous stimulation). The choice of the parameters was 
based on the manufacturer’s recommendations and on the clinical expertise of the 
therapists (GH and NH). These parameters are comparable to the parameters used by 
Binder and colleagues (1984) who noted a favorable effect of PEMF on pain (over 
placebo) in a population of patients with persistent rotator cuff tendinitis. The same 
apparatus was used for the sham intervention, except that the applicators were connected 
to the second (inactive) channel. Thus, the lights of the apparatus were on, but no PEMF 
was delivered. Wooden chairs were used to avoid electromagnetic field interference. 
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2.4 Experimental design 
Participants were assigned in a double-blind, randomized, crossover design to 
receive, alternately, real and sham PEMF. Participants were enrolled in the study by KB, 
PB and MP, and were assigned to the treatment conditions by GL.  The order of 
presentation of the two conditions was determined using a random number table, 
prepared by the statistician of the Research Center on Aging. The table was kept in all 
time in the office of the principal investigator (GL).  This resulted in 12 participants 
receiving real PEMF before sham PEMF, and 12 participants receiving sham PEMF 
before real PEMF. Every participant was submitted to the two conditions (approximately 
1-week interval). Both the participant and evaluator were blinded to the treatment being
given. The tonic heat pain test was always performed without the person responsible for 
the application of PEMF being present. 
2.5 Statistical analysis 
The study was designed to detect a difference of 15 points on the NRS between real 
and sham PEMF. To detect this difference, with 80% power and a 5% significance level, 
we calculated that 24 participants had to be enrolled in the study (estimated standard 
deviation of 25, based on preliminary work). Because of the relatively low number of 
subjects included in this study and because visual inspection of the histograms did not 
allow us to assume that the data were normally distributed, non-parametric tests were 
used. Specifically, Friedman’s tests and Wilcoxon Signed-Rank tests were used to 
compare pain intensity and pain unpleasantness across the different time measures 
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(before and after PEMF application) and between the two conditions for the same time 
measure (real and sham PEMF).   
To compare temporal summation between the different time measures and 
determine if real PEMF affects excitatory pain mechanisms, we calculated delta scores 
(representing the difference between the pain intensity scores reported at 120 sec and the 
pain intensity scores reported at 60 sec of stimulation). Wilcoxon Signed-Rank tests were 
used to contrast the temporal summation values (delta scores) obtained before and after 
real PEMF. All tests were performed using SPSS (version 15.0 for Windows®, Chicago, 
IL, USA). Differences were considered to be significant if p < 0.05 was obtained. 
3. Results 
3.1 Baseline thermode measures 
Every participant were recruited and tested during the months of March and April 
2012. All 24 participants completed the study and were included in the analyses. No 
important harms or side-effects were reported. 
The pain intensity ratings obtained at baseline showed that every participant 
experienced pain during the thermode test (all pain intensity scores > 13). The thermode 
temperatures used for the real and sham PEMF conditions were 46.2 ± 1.5 °C and 46.0 ± 
1.7 °C, respectively. A Wilcoxon Signed-Rank test revealed that there was no difference 
between these two temperatures (p = 0.29). 
3.2 Effect of PEMF on pain intensity and pain unpleasantness 
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The average pain intensity and pain unpleasantness scores obtained at baseline and 
at each time measure are presented in Figures 1A and 1B. As it can be seen from these 
figures, there was no change in pain intensity and pain unpleasantness after real or sham 
PEMF when compared to baseline (all p-values > .15). Head-to-head comparisons for 
each time measure revealed no difference between real and sham conditions (all p-values 
> .10). 
3.3 Effect of PEMF on temporal summation 
The temporal summation observed at baseline and immediately after real PEMF 
application is shown in Figure 2. As it can be seen in this figure, there was a slight 
increase in pain during the last minute of stimulation for both the baseline and post-
PEMF conditions. Similar results were obtained for all time measures (i.e., at baseline, 0 
min, 15 min, 30 min, 45 min and 60 min post-PEMF; see Figure 3), suggesting that 
PEMF had no effect on temporal summation.  The Friedman test confirmed that there 
was no difference between the temporal summation delta scores (pain intensity at 120 
seconds - pain intensity at 60 seconds) obtained at baseline, 0 min, 15 min, 30 min, 45 
min and 60 min post-PEFM (p = .74). 
3.4 Conditioning effect and influence of sex on PEMF analgesia Because previous 
studies have observed that the conditioning effects provided by the experience of 
placebos can influence the results of clinical trials (Andre-Obadia et al. 2011; Leonard et 
al. 2010; Leonard et al. 2012), we performed between-subject analyses to determine if the 
pattern of analgesic response observed following real PEMF application was influenced 
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by the order of presentation. To do this, delta pain scores, representing pain reductions 
experienced after real PEMF application (delta pain score = pain at baseline – pain after 
PEMF), were calculated and compared between participants who received sham PEMF 
during their first session and those who received real PEMF during their first session. The 
analyses revealed that the order of presentation did not influence the pattern of results 
(i.e., similar analgesia following real PEMF for participants who received sham PEMF 
during their first visit and participants who received real PEMF during their first visit; p > 
.66). 
  The delta pain scores were also used to assess whether the sex of the participants 
influenced PEMF analgesia. The analysis showed that there was no difference in the delta 
pain scores between men and women (delta scores = 4 ± 18 and 6 ± 20, respectively; p = 
0.72), suggesting that sex had no effect on PEMF analgesia. 
4. Discussion  
In the present study, we examined whether experimental pain (induced by a tonic 
heat pain paradigm) could be modulated by PEMF. We observed no change in pain 
intensity, pain unpleasantness and temporal summation following PEMF application, 
suggesting that PEMF does not affect tonic experimental pain. 
In the last decades, many studies have been conducted to evaluate the analgesic 
effect of PEMF. Positive results have been reported in various pain disorders, including 
inflammatory and post-operative pain conditions (Binder et al. 1984; Cheing et al. 2005; 
Foley-Nolan et al. 1992; Heden and Pilla 2008; Uzunca et al. 2007). More contradictory 
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findings have been observed for painful diabetic polyneuropathy, with some authors 
showing positive (Graak et al. 2009; Musaev et al. 2003) and others showing negative 
(Weintraub et al. 2009; Wrobel et al. 2008) results. Contradictory findings have also been 
reported for chronic pain conditions. For instance, Shupak and colleagues observed a 
beneficial effect of PEMF on pain in rheumatoid arthritis and fibromyalgia patients 
(Shupak et al. 2006), and similar results were reported by Foley and colleagues in 
patients suffering from persistent neck pain (Foley-Nolan et al. 1990). Alternately, others 
found no benefit for patients suffering of knee osteoarthritis (Ay and Evcik 2009; 
Ozguclu et al. 2010; Vavken et al. 2009) and chronic localized musculoskeletal pain 
(Thomas et al. 2007). These results suggest that PEMF may be useful to decrease pain in 
some, but not all, pain patient populations. 
Interestingly, many conditions in which PEMF was shown to be effective (e.g., 
tendinitis, rheumatoid arthritis) are characterised by inflammatory pain (Binder et al. 
1984; Cheing et al. 2005; Foley-Nolan et al. 1992; Heden and Pilla 2008; Uzunca et al. 
2007). These observations raise the possibility that the analgesic effect of PEMF could be 
attributable to an effect of PEMF on inflammation. This hypothesis is supported by the 
results of Vincenzi and colleagues and Selvam and colleagues who observed that PEMF 
increases the anti-inflammatory effect of  A₂A and A₃ adenosine receptors (Petersen et 
al. 1988) and restores plasma membrane calcium ATPase activity (Grady et al. 1995). 
Future studies, studying the effect of PEMF on both pain and inflammatory markers are 
necessary before we can come to any final conclusions. 
13 
 
Other studies have suggested that PEMF analgesia could be due to the effect of 
PEMF on NO and on the CaM signaling pathways (Diniz et al. 2002; Fitzsimmons et al. 
2008; Pilla 2013). For instance, Fitzsimmons et al. (2008) showed that PEMF could 
promote the proliferation of chondrocytes via a CaM-dependant NO signaling cascade. 
Although these results suggest that the beneficial effect of PEMF on pain could be due to 
the effect of PEMF on chondrocytes and tissue repair, they do not exclude the possibility 
that PEMF could also directly influence pain. For example, in osteoarthritis patients, NO 
could improve blood flow to the affected joint (thus reducing ischemic pain) and activate 
opioid pathways (Abramson 2008; Staniland et al. 2010). The absence of analgesic effect 
noted in the present study suggests that the effect of PEMF on osteoarthritis pain may be 
due more to an effect of PEMF on chondrocytes and/or blood flow than to an effect on 
opioid pathways. 
4.1 Effect of PEMF on experimental pain 
Contrary to clinical pain paradigms, experimental pain paradigms allow researchers 
to standardize pain across participants and minimize time-related fluctuations in pain 
ratings. Many experimental pain paradigms also offer the advantage of avoiding tissue 
damage and inflammation, hence allowing researchers to determine if a given treatment 
directly influences pain perception. To our knowledge, very few studies looked at the 
effect of PEMF on experimental pain (Fernandez et al. 2007; Kortekaas et al. 2013; 
Shupak et al. 2004). In one study, conducted by Shupak et al. (2004), the authors 
evaluated the effect of PEMF on thermal non-nociceptive and nociceptive thresholds in a 
group of healthy volunteers. They observed that PEMF did not affect the thermal sensory 
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threshold, but significantly increased thermal pain thresholds, hence suggesting a specific 
effect of PEMF on pain perception. These beneficial effects of PEMF on experimental 
pain were challenged by another study, conducted by Fernandez et al. (2007), who noted 
no difference in pain intensity between real and sham PEMF in a group of healthy 
volunteers who received hypertonic saline injections into the brachioradialis muscle of 
the non-dominant arm.  In their study, Shupak and colleagues used pain thresholds to 
document the effect of PEMF on pain, while Fernandez and colleagues used a tonic pain 
stimulation paradigm (hypertonic saline infusion; perceived pain measured with a visual 
analog scale). These observations, as well as the results from the present study, indicate 
that the nature of the experimental paradigm (i.e., pain threshold vs tonic pain procedure) 
can affect the pattern of results of PEMF pain studies. We believe that tonic pain 
paradigms more closely mimic clinical pain conditions than do research paradigms based 
on the evaluation of pain thresholds (Rainville et al. 1992). 
4.2 Pain unpleasantness 
In 2010, Robertson and colleagues (2010) evaluated the effect of a whole-body 
electromagnetic field on the activity of the cerebral structures implicated in pain 
perception. They noted that the increased cerebral activity observed during the 
application of an acute thermal pain paradigm was significantly reduced in participants 
who were exposed to a real electromagnetic field, compared to participants who were 
exposed to a sham electromagnetic field. These changes were noted in the insula and 
anterior cingulate cortex, two brain regions known to play a key role in the affective 
component of pain (Marchand 2010; Rainville et al. 1997). However, in their study, 
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Robertson and colleagues did not measure pain intensity and pain unpleasantness, hence 
precluding any final conclusion regarding the effect that electromagnetic fields can have 
on subjective pain. In the present study, we observed no difference between real and 
sham PEMF for both pain intensity and pain unpleasantness. Our results suggest that 
PEMF does not affect the sensory-discriminative or motive-affective components of pain, 
at least when applied locally. Perhaps a more general application (i.e., whole-body field 
exposition), like the one used by Robertson and colleagues, could lead to different 
outcomes. 
4.5 Study limitations 
In this study, PEMF therapy was applied for 10 minutes with a frequency of 60 Hz 
and a field density of 9 Gauss. The choice of these parameters was based on the 
manufacturer’s recommendations, the clinical expertise of the therapists (GH and NH) 
and the methodology of a previous PEMF study showing beneficial results (Binder et al. 
1984).  However, to date, the optimal stimulation parameters for PEMF have not yet been 
established. Different results would have perhaps been obtained if other PEMF 
parameters had been used. 
Another important criticism that could be addressed to the present study is the use of 
an experimental pain paradigm rather than a clinical pain paradigm. Indeed, several of the 
previous studies looking at the effect of PEMF on pain employed clinical pain paradigms, 
and some could wonder if the results of this study (based on pain ratings obtained on 
healthy volunteers during prolonged heat stimulation) would also have been obtained in 
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pain patients. Without refuting the fact that experimental pain paradigms have less 
external validity than clinical pain paradigms, one has to remember that the former has on 
the counterpart the advantage of increasing the internal validity due to the constant 
stimulation parameters employed at each time measure. As mentioned previously, the use 
of an experimental pain paradigm was preferred to a clinical pain paradigm in order to 
exclude the effect that PEMF could have on inflammation and tissue repair and better 
circumscribe the “true” effect of PEMF on pain. That being said, we must remember that 
the current results can only be applied to the pain modality used in the present study (i.e., 
tonic heat pain). Perhaps different results would be obtained with another pain model. 
Results from studies on transcutaneous electrical nerve stimulation (TENS), showing that 
the analgesic effect of TENS tends to vary across different pain models (see for instance 
Claydon et al. 2011 for a review) somewhat support such an interpretation. Future studies 
looking into the analgesic effect of PEMF with other experimental pain paradigms, 
should be conducted before any final conclusions can be drawn. 
5. Conclusion
 In conclusion, local application of PEMF does not appear to influence pain 
intensity and pain unpleasantness. Although it is still possible that PEMF may decrease 
pain in certain clinical conditions, the current results suggest that the analgesic effect 
noted with these patients is probably due to an effect of PEMF on inflammation and/or 
tissue healing, rather than to a direct effect of PEMF on pain. Future research is essential 
to confirm these results and to determine the optimal parameters of PEMF. 
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Figure Legends 
Figure 1. Pain intensity and unpleasantness 
Pain intensity (A) and unpleasantness (B) were evaluated with a numerical pain rating 
scale (0-100 mm) before (baseline) and after PEMF application. When compared to 
baseline, there was no change in pain ratings after both real and sham PEMF (all p-values 
> 0.15).
A 
B 
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Figure 2. Temporal summation 
Pain perception (pain intensity) gradually increased during the application of the tonic 
nociceptive stimuli. This gradual rise in pain was observed both before and immediately 
after real PEMF application. 
Figure 3. Effect of PEMF on temporal summation 
The pain intensity scores were higher at 120 sec compared to 60 sec, a phenomenon 
attributable to temporal summation. There was no difference between the temporal 
summation delta scores obtained at baseline, 0 min, 15 min, 30 min, 45 min and 60 min 
post-PEFM (p = .74). 
